Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CICCIA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.552
EU - Europa 3.790
AS - Asia 1.505
AF - Africa 25
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 16.894
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.524
IT - Italia 1.550
CN - Cina 871
FI - Finlandia 551
SG - Singapore 439
UA - Ucraina 388
DE - Germania 277
IE - Irlanda 240
GB - Regno Unito 232
SE - Svezia 129
RU - Federazione Russa 114
FR - Francia 86
RO - Romania 69
IN - India 54
BE - Belgio 43
KR - Corea 37
HK - Hong Kong 30
CA - Canada 25
TR - Turchia 23
NL - Olanda 22
CH - Svizzera 21
ES - Italia 17
CI - Costa d'Avorio 14
CZ - Repubblica Ceca 11
IR - Iran 11
GR - Grecia 10
EG - Egitto 9
JP - Giappone 9
AT - Austria 6
BR - Brasile 6
UZ - Uzbekistan 6
DK - Danimarca 5
TW - Taiwan 5
AU - Australia 4
EU - Europa 4
PT - Portogallo 4
AR - Argentina 3
BG - Bulgaria 3
IL - Israele 3
MY - Malesia 3
PK - Pakistan 3
PL - Polonia 3
CL - Cile 2
LB - Libano 2
LT - Lituania 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
GM - Gambi 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
VN - Vietnam 1
Totale 16.894
Salva come PNG Salva come JPEG
Città #
Fairfield 1.963
Ashburn 1.147
Woodbridge 1.005
Seattle 817
Chandler 790
Wilmington 774
Houston 709
Cambridge 619
Ann Arbor 545
Singapore 338
Des Moines 303
Palermo 285
Medford 254
Dublin 237
Jacksonville 201
Altamura 165
Nanjing 164
Princeton 163
San Diego 136
Lawrence 126
Boardman 106
Jinan 89
Santa Clara 87
Dearborn 86
New York 84
Beijing 81
Milan 81
Shenyang 68
Ludwigshafen am Rhein 64
Tulsa 61
Nanchang 59
Hebei 46
Brussels 42
Changsha 41
London 40
Tianjin 40
Zhengzhou 39
Jiaxing 38
Rome 38
Phoenix 34
Seongnam 31
Ningbo 30
Kumar 25
San Paolo di Civitate 25
Falls Church 24
Los Angeles 22
Saint Petersburg 22
Bologna 21
Guangzhou 21
Helsinki 21
Venice 21
Central 19
Chicago 19
Pune 19
Kilburn 18
Munich 18
Taizhou 18
Verona 18
Columbus 17
Ottawa 17
Lanzhou 16
Naples 16
San Mateo 16
Hangzhou 15
Orange 15
Abidjan 14
Fuzhou 14
Izmir 13
Catania 12
Redmond 12
Redwood City 12
West Jordan 12
Genova 11
Haikou 11
Auburn Hills 10
Cagliari 10
Düsseldorf 10
Norwalk 10
Tehran 10
Dallas 9
Napoli 9
Bremen 8
Florence 8
Hong Kong 8
Kunming 8
Turin 8
Brno 7
Taiyuan 7
Tappahannock 7
Den Haag 6
Hefei 6
Islington 6
Wandsworth 6
Barcelona 5
Bergamo 5
Edinburgh 5
Floridia 5
Hounslow 5
Madrid 5
Messina 5
Totale 12.768
Salva come PNG Salva come JPEG
Nome #
Malattia di KiKuchi-Fujimoto e lupus eritematoso sistemico: quale connessione ?. 415
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis 246
Intestinal Involvement in Kawasaki Disease 205
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 199
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 197
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 194
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 189
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 185
New insights into the pathogenesis of giant cell arteritis 185
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs 182
IL-17 polarization of MAIT cells is derived from the activation of two different pathways 180
Downregulation of miRNA17-92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis 176
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 174
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 172
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 169
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 169
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 167
Ectopic expression of CXCL13, BAFF, APRIL and LT-ß is associated with artery tertiary lymphoid organs in giant cell arteritis 167
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 165
Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: A prospective open-label study 163
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes 162
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis 159
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 159
Pro-inflammatory CX3CR1+ CD59+ TL1A+ IL-23+ monocytes are expanded in patients with Ankylosing Spondylitis and modulate ILC3 immune functions 157
Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response 154
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis 153
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 152
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 151
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. 150
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. 149
Brief Report: Intestinal dysbiosis in ankylosing spondylitis 149
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 149
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis 148
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage. 147
Associazione tra spondiloartrite e gammopatia monoclonale: tre casi clinici 146
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 145
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity. 144
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. 144
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 143
Giant cell arteritis associated with chronic active Epstein-Barr virus infection. 142
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 142
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 136
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis 135
Subclinical gut inflammation in ankylosing spondylitis 134
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 134
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. 131
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 130
Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications 129
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 129
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 128
IVIG in APS pregnancy 126
T2-mapping of the sacroiliac joints at 1.5 Tesla: a feasibility and reproducibility study 125
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. 124
Intestinal dysbiosis and innate immune responses in axial spondyloarthritis 124
Ruolo della terapia con aspirina e con immunoglobuline endovena nella poliabortività associata a sindrome da anticorpi anti-fosfolipidi 122
Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis 122
Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome. 122
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 122
Interleukin-9 and T helper type 9 cells in rheumatic diseases 119
Autophagy in the pathogenesis of ankylosing spondylitis 119
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 115
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 115
Arteriosclerosi ed artrite reumatoide: ruolo della terapia biologica 114
Atherosclerosis in females patients with rheumatoid arthritis; a two years follow-up. 114
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 113
La determinazione degli anticorpi anti-peptide ciclico citrullinato è utile nel discriminare pazienti con artrite reumatoide da quelli con poliartrite associata a tiroidite cronica autoimmune 112
Prevalence of headache in patients with Behçet's disease without overt neurological involvement 112
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 112
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies 110
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. 109
Increased expression of interleukin-22 in patients with giant cell arteritis 108
Atherosclerosis in female patients with rheumatoid arthritis: a two years of follow up 107
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome 105
Pathogenesis of polymyalgia rheumatica 105
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 105
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. 104
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 103
Atherosclerosis in female patients with rheumatoid arthritis; a two years follow-up 102
Vasculiti dei piccoli vasi. 101
Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis 100
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 100
Disfunzione diastolica in pazienti affetti da artrite reumatoide: ruolo della terapia con anti-TNFα 99
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 99
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 98
Invariant NKT cells and rheumatic disease: Focus on primary sjogren syndrome 98
Disfunzione diastolica in pazienti affetti da artrite reumatoide:ruolo della terapia con anti-TNF 97
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 96
The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis. 95
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity 95
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response 95
Response to: 'Artery tertiary lymphoid organs in giant cell arteritis are not exclusively located in the media of temporal arteries' by Graver et al 94
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 93
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 93
Histopathology of the gut in rheumatic diseases 93
IBD e malattie reumatiche. Malattia di Crohn e spondilite anchilosante: una patogenesi comune? 92
Interstitial lung disease in systemic sclerosis: current and future treatment 92
Aterosclerosi e artrite reumatoide: ruolo della twerapia biologica 91
Rapida induzione di remissione di un caso di malattia di Vogt-Koyonagi-Harada recidivante dopo terapia con infliximab 91
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study. 90
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 89
Totale 13.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.366 0 0 0 0 449 514 400 420 399 440 594 150
2020/20212.806 207 199 266 248 204 175 214 218 252 294 278 251
2021/20222.038 117 401 71 76 58 112 101 145 209 287 135 326
2022/20232.745 278 481 50 257 299 385 269 212 288 37 131 58
2023/20241.210 72 181 73 85 99 248 147 72 24 48 35 126
2024/2025787 71 221 179 267 49 0 0 0 0 0 0 0
Totale 18.011